| Anja Jokela, | |
|
3 Timber Ln, South Burlington, VT 05403-7205 | |
| (802) 847-8500 | |
| Not Available |
| Full Name | Anja Jokela |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 3 Timber Ln, South Burlington, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467815225 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
The study is based on the results obtained in the Digital Mammography DREAM Challenge, an international competition led by IBM where researchers from the Instituto de Física Corpuscular have participated along with scientists from the UPV's Institute of Telecommunications and Multimedia Applications.
Rapid DNA sequencing may soon become a routine part of each individual's medical record, providing enormous information previously sequestered in the human genome's 3 billion nucleotide bases. This week's NEWSFOCUS section of the journal Science describes recent advances in sequencing technology.
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive therapy appear to have an impaired immunity response to SARS-CoV-2, the coronavirus that causes COVID-19, vaccines. Patients currently on glucocorticoids or B-cell depleting therapy appear to have an even more severely impeded vaccine response.
In two ancillary studies of two multi-center international clinical trials led by the University of Southern California Eye Institute, the injectable drug ocriplasmin appears to improve vision among patients suffering from symptomatic vitreomacular adhesion (VMA), a condition related to the aging eye that could cause permanent vision loss if left untreated.
Profil Institute for Clinical Research, an clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today a strategic collaboration with Gubra ApS, a metabolic preclinical and drug discovery company, to combine expertise and resources to discover and translate into clinical research novel drug targets, compounds and biomarkers addressing metabolic disease.
› Verified 6 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
The study is based on the results obtained in the Digital Mammography DREAM Challenge, an international competition led by IBM where researchers from the Instituto de Física Corpuscular have participated along with scientists from the UPV's Institute of Telecommunications and Multimedia Applications.
Rapid DNA sequencing may soon become a routine part of each individual's medical record, providing enormous information previously sequestered in the human genome's 3 billion nucleotide bases. This week's NEWSFOCUS section of the journal Science describes recent advances in sequencing technology.
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive therapy appear to have an impaired immunity response to SARS-CoV-2, the coronavirus that causes COVID-19, vaccines. Patients currently on glucocorticoids or B-cell depleting therapy appear to have an even more severely impeded vaccine response.
In two ancillary studies of two multi-center international clinical trials led by the University of Southern California Eye Institute, the injectable drug ocriplasmin appears to improve vision among patients suffering from symptomatic vitreomacular adhesion (VMA), a condition related to the aging eye that could cause permanent vision loss if left untreated.
Profil Institute for Clinical Research, an clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today a strategic collaboration with Gubra ApS, a metabolic preclinical and drug discovery company, to combine expertise and resources to discover and translate into clinical research novel drug targets, compounds and biomarkers addressing metabolic disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anja Jokela, 1401 Madison St Ste 100, Seattle, WA 98104-1316 Ph: () - | Anja Jokela, 3 Timber Ln, South Burlington, VT 05403-7205 Ph: (802) 847-8500 |
News Archive
The study is based on the results obtained in the Digital Mammography DREAM Challenge, an international competition led by IBM where researchers from the Instituto de Física Corpuscular have participated along with scientists from the UPV's Institute of Telecommunications and Multimedia Applications.
Rapid DNA sequencing may soon become a routine part of each individual's medical record, providing enormous information previously sequestered in the human genome's 3 billion nucleotide bases. This week's NEWSFOCUS section of the journal Science describes recent advances in sequencing technology.
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive therapy appear to have an impaired immunity response to SARS-CoV-2, the coronavirus that causes COVID-19, vaccines. Patients currently on glucocorticoids or B-cell depleting therapy appear to have an even more severely impeded vaccine response.
In two ancillary studies of two multi-center international clinical trials led by the University of Southern California Eye Institute, the injectable drug ocriplasmin appears to improve vision among patients suffering from symptomatic vitreomacular adhesion (VMA), a condition related to the aging eye that could cause permanent vision loss if left untreated.
Profil Institute for Clinical Research, an clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today a strategic collaboration with Gubra ApS, a metabolic preclinical and drug discovery company, to combine expertise and resources to discover and translate into clinical research novel drug targets, compounds and biomarkers addressing metabolic disease.
› Verified 6 days ago
Kate Lamancuso, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Timber Ln, South Burlington, VT 05403 Phone: 802-847-8500 Fax: 802-847-6140 | |
Dr. Sepinoud Bazel, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 20 Kimball Ave Ste 303, South Burlington, VT 05403 Phone: 802-495-5817 | |
David Lisle, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 192 Tilley Dr, Orthopaedic Specialty Center, South Burlington, VT 05403 Phone: 802-847-2663 | |
Dr. Robert A Luebbers, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1775 Williston Rd, South Burlington, VT 05403 Phone: 802-847-8500 Fax: 802-847-6140 | |
Micheal R Sirois, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1775 Williston Rd, South Burlington, VT 05403 Phone: 802-847-8500 Fax: 802-860-4324 | |
Mrs. Kathryn Ridgely Applegate, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Tilley Dr Ste 201, South Burlington, VT 05403 Phone: 802-847-5550 | |
Dr. Aaron W Reiter, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Timber Ln, South Burlington, VT 05403 Phone: 802-847-7200 |